WallStreetZenWallStreetZen

NASDAQ: FULC
Fulcrum Therapeutics Inc Stock Ownership - Who owns Fulcrum Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Fulcrum Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alan EzekowitzDirector2026-06-2618,000$3.65
$65.61kSell
Robert J. GouldDirector2026-02-0215,000$10.72
$160.86kSell
Robert J. GouldDirector2026-01-0215,000$11.87
$178.10kSell
Robert J. GouldDirector2026-01-0215,000$10.87
$163.10kSell
Curtis Gale OltmansChief Legal Officer2025-12-153,452$12.92
$44.60kSell
Ra Capital Management LP10% Owner2025-12-081,377,020$13.33
$18.36MSell
Ra Capital Management LP10% Owner2025-12-082,706,397$14.28
$38.65MSell
Ra Capital Management LP10% Owner2025-12-0891,722$14.98
$1.37MSell
Robert J. GouldDirector2025-11-1915,000$11.03
$165.50kSell

1 of 1

FULC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FULC insiders and whales buy or sell their stock.

FULC Shareholders

What type of owners hold Fulcrum Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP19.59%13,053,960$50.13MInsider
Suvretta Capital Management LLC9.85%6,561,111$25.19MInstitution
Ra Capital Management LP9.09%6,053,960$23.25MInstitution
Mark J. Levin9.07%6,046,425$23.22MInsider
Blackrock Inc8.09%5,390,593$20.70MInstitution
Tcg Crossover Management LLC7.88%5,250,000$20.16MInstitution
Braidwell LP4.70%3,134,922$12.04MInstitution
Nantahala Capital Management LLC4.58%3,050,040$11.71MInstitution
Vanguard Capital Management LLC4.04%2,692,948$10.34MInstitution
Third Rock Ventures III LP3.75%2,499,343$9.60MInsider

1 of 3

FULC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FULC71.27%28.73%Net SellingNet Selling
AVXL43.15%4.79%Net Buying
IVVD71.04%28.96%Net Selling
OBIO36.71%63.29%Net BuyingNet Selling
SLGL35.80%64.20%Net BuyingNet Buying
View Top Biotech Stocks

Fulcrum Therapeutics Stock Ownership FAQ

Who owns Fulcrum Therapeutics?

Fulcrum Therapeutics (NASDAQ: FULC) is owned by 107.63% institutional shareholders, 43.38% Fulcrum Therapeutics insiders, and 0.00% retail investors. Ra Capital Management LP is the largest individual Fulcrum Therapeutics shareholder, owning 13.05M shares representing 19.59% of the company. Ra Capital Management LP's Fulcrum Therapeutics shares are currently valued at $48.56M.

If you're new to stock investing, here's how to buy Fulcrum Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.